X-linked severe combined immunodeficiency: genes and variants
Explore variant evidence for X-linked severe combined immunodeficiency across 1 analyzed protein (IL2RG). Linked ClinVar records include 30 pathogenic or likely pathogenic variants, 74 variants of uncertain significance and 14 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to X-linked severe combined immunodeficiency
IL2RG: Cytokine receptor common subunit gamma
It is the shared signaling chain used by receptors for several interleukins required for lymphocyte development and survival. Loss-of-function variants cause X-linked severe combined immunodeficiency with profound T-cell and natural-killer-cell deficiency.
30 ClinVar pathogenic / likely pathogenic and 88 uncertain variants in IL2RG have source records linked to X-linked severe combined immunodeficiency. Association strength is not clinical gene validity.
Where X-linked severe combined immunodeficiency variants cluster
- IL2RG Fibronectin type-III (positions 156–253): 15 of 28 ClinVar pathogenic / likely pathogenic variants, 2.0× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to X-linked severe combined immunodeficiency
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| IL2RG R222C | 222 | Fibronectin type-III | Pathogenic / likely pathogenic (★★★) |
| IL2RG R224P | 224 | Fibronectin type-III | Pathogenic / likely pathogenic (★★★) |
| IL2RG R226C | 226 | Fibronectin type-III | Pathogenic / likely pathogenic (★★★) |
| IL2RG R224W | 224 | Fibronectin type-III | Pathogenic / likely pathogenic (★★★) |
| IL2RG C62R | 62 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| IL2RG C62S | 62 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| IL2RG C182Y | 182 | Fibronectin type-III | Pathogenic / likely pathogenic (★★★) |
| IL2RG R226H | 226 | Fibronectin type-III | Pathogenic / likely pathogenic (★★★) |
| IL2RG V152G | 152 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| IL2RG E68K | 68 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| IL2RG W240R | 240 | Fibronectin type-III | Pathogenic / likely pathogenic (★★) |
| IL2RG R285Q | 285 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| IL2RG M1T | 1 | Pathogenic / likely pathogenic (★★) | |
| IL2RG A156V | 156 | Fibronectin type-III | Pathogenic / likely pathogenic (★★) |
| IL2RG G114C | 114 | Extracellular | Pathogenic / likely pathogenic (★) |
| IL2RG C115Y | 115 | Extracellular | Pathogenic / likely pathogenic (★) |
| IL2RG C115F | 115 | Extracellular | Pathogenic / likely pathogenic (★) |
| IL2RG R222G | 222 | Fibronectin type-III | Pathogenic / likely pathogenic (★) |
| IL2RG G114S | 114 | Extracellular | Pathogenic / likely pathogenic (★) |
| IL2RG L172Q | 172 | Fibronectin type-III | Pathogenic / likely pathogenic (★) |
| IL2RG C182S | 182 | Fibronectin type-III | Pathogenic / likely pathogenic (★) |
| IL2RG S225R | 225 | Fibronectin type-III | Pathogenic / likely pathogenic (★) |
| IL2RG L172M | 172 | Fibronectin type-III | Pathogenic / likely pathogenic (★) |
| IL2RG Y125C | 125 | Extracellular | Pathogenic / likely pathogenic (★) |
| IL2RG L146P | 146 | Extracellular | Pathogenic / likely pathogenic (★) |
| IL2RG L162R | 162 | Fibronectin type-III | Pathogenic / likely pathogenic (★) |
| IL2RG C231Y | 231 | Fibronectin type-III | Pathogenic / likely pathogenic (★) |
| IL2RG G232V | 232 | Fibronectin type-III | Pathogenic / likely pathogenic (★) |
| IL2RG S238N | 238 | Fibronectin type-III | Pathogenic / likely pathogenic (★) |
| IL2RG L14P | 14 | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in X-linked severe combined immunodeficiency
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| IL2RG W240C | 240 | Fibronectin type-III | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; W240R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| IL2RG G232R | 232 | Fibronectin type-III | Uncertain (★★★) | +6: 2 other pathogenic changes within 3 positions; G232V at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.91 |
Which prediction tools work for X-linked severe combined immunodeficiency
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 99 out of 100
- MutPred: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 96 out of 100
- PolyPhen-2: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 92 out of 100
- MetaSVM: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 78 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to X-linked severe combined immunodeficiency
- Renal cell carcinoma, also linked to IL2RG
- Multiple sclerosis, also linked to IL2RG
- Combined immunodeficiency, also linked to IL2RG
Frequently asked questions
Which genes have records linked to X-linked severe combined immunodeficiency?
This view contains 1 analyzed proteins: IL2RG. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 30 pathogenic or likely pathogenic variants, 74 variants of uncertain significance and 14 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 2 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 186 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center